Actively Recruiting

Phase Not Applicable
Age: 30Days - 1Year
All Genders
NCT06587165

Quantifying New Heart Muscle Cells

Led by Weill Medical College of Cornell University · Updated on 2025-07-28

30

Participants Needed

1

Research Sites

605 weeks

Total Duration

On this page

Sponsors

W

Weill Medical College of Cornell University

Lead Sponsor

N

National Heart, Lung, and Blood Institute (NHLBI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Regenerative therapies could provide new ways of treating heart failure. Unlike many organs in the human body, such as the skin and the GI tract, the ability to regenerate heart muscle decreases after birth, but the precise timing of this decrease and how this decrease is altered in heart disease are uncertain. The investigators will use an innovative approach to quantify cellular heart regeneration in pediatric patients, an appropriate population for determining this decline as well as the potential for reactivating heart muscle regeneration. The study has now been registered on ClinicalTrials.gov, despite its initiation on July 23, 2015, as registration was not mandated at the original study site, the University of Pittsburgh Medical Center. However, following the transfer of the study to Weill Cornell Medicine, adherence to institutional requirements necessitated its registration on ClinicalTrials.gov.

CONDITIONS

Official Title

Quantifying New Heart Muscle Cells

Who Can Participate

Age: 30Days - 1Year
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 30 days to 1 year undergoing scheduled elective cardiac surgery
  • Patients with heart disease types, including Tetralogy of Fallot with Pulmonary Stenosis, likely requiring surgery with myocardial resection
  • Diagnosis of heart disease with high likelihood of surgery involving routine myocardial tissue removal available for research
Not Eligible

You will not qualify if you...

  • Patients unlikely to have myocardial resection as part of their surgery

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Weill Cornell Medicine

New York, New York, United States, 10065

Actively Recruiting

Loading map...

Research Team

R

Rashida Blackwood, BS, MPH

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here